Rue Juliette Wytsmanstraat 14 1050 Brussels | Belgium T + 32 2 642 51 11 | F + 32 2 642 50 01 info@wiv-isp.be | www.wiv-isp.be

Klinische Biologie

GLOBAAL RAPPORT EKE HbA1c - EURO 2011.08

Target HbA1c = 9.6% (Referentiemethode NGSP/DCCT) 09 JUNI 2011

Uw individueel rapport kunt u opvragen via de site https://biocli.iph.fgov.be/toolkit/login/login.cfm

De enquêtecoördinatoren Master Y. Lenga Dr. K. Vernelen

INSTRUMENT RESULT (Mean) N SD CV Bias Bias %

Cobas 6000 10.3 2 0.2 2.1 0.7 6.8

Cobas(501-311-111)TinaQuant; whole blood 9.7 5 0.3 2.9 0.1 1.3

D-10_A1c_Program 9.7 14 0.2 2.3 0.1 1.2

Integra; TinaQuant; whole blood 9.9 2 0.1 0.7 0.3 3.6

Integra; whole blood 9.8 1 **** **** 0.2 2.1

Menarini HA-8160 TP 9.8 6 0.2 1.7 0.2 1.7

Menarini HA-8160 VP 9.8 75 0.2 2.3 0.2 1.9

TOSOH G7 9.7 9 0.1 1.4 0.1 1.5

TOSOH G8 9.8 27 0.1 1.3 0.2 1.8

Vantage 10.1 1 **** **** 0.5 5.2

Variant 10.1 1 **** **** 0.5 5.2

Variant II_HbA1c 9.7 4 0.1 1.2 0.1 1.0

Variant-II_DUAL_A1c_Program 9.8 2 0.1 0.7 0.3 2.6

Variant-II_Turbo_A1c_Program 10.0 5 0.2 2.4 0.4 4.4

Vitros 5,1 FS 10.3 2 0.4 3.4 0.7 6.8